MRPL53
Large ribosomal subunit protein mL53
Also known as: RM53_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96EL3
- Gene
- MRPL53
- Ensembl
- ENSG00000204822
- Chromosome
- 2
- Canonical length
- 112 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. A pseudogene corresponding to this gene is found on chromosome 1p. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
112 residues, UniProt reviewed canonical sequence.
>Q96EL3|MRPL53
1 MAAALARLGL RPVKQVRVQF CPFEKNVEST RTFLQTVSSE KVRSTNLNCS VIADVRHDGS
61 EPCVDVLFGD GHRLIMRGAH LTALEMLTAF ASHIRARDAA GSGDKPGADT GRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRPL53 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 205 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 205 nTPM
- heart muscle: 179 nTPM
- adrenal gland: 153 nTPM
- kidney: 145 nTPM
- choroid plexus: 124 nTPM
- liver: 123 nTPM
Single-cell type
- parietal cells: 34 nCPM
- epididymal principal cells: 30 nCPM
- enterocytes: 23 nCPM
- neuroendocrine cells: 22 nCPM
- epididymal efferent duct absorptive cells: 21 nCPM
- epididymal efferent duct ciliated cells: 19 nCPM
Immune cell
- naive B-cell: 369 nTPM
- plasmacytoid DC: 362 nTPM
- memory B-cell: 352 nTPM
- total PBMC: 346 nTPM
- classical monocyte: 295 nTPM
- naive CD4 T-cell: 283 nTPM
Brain region
- choroid plexus: 62 nTPM
- cerebellum: 57 nTPM
- white matter: 56 nTPM
- spinal cord: 52 nTPM
- medulla oblongata: 49 nTPM
- hypothalamus: 48 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0.28
- gnomAD missense Z
- -0.64
- DepMap mean gene effect
- -0.57
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Large ribosomal subunit protein mL53
- Mitochondrial Large Ribosomal Subunit mL53
- 39S ribosomal protein L53/MRP-L53
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MRPL53 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRPL53 as an antibody target. Whether an autoantibody or antibody against MRPL53 could matter depends on whether native MRPL53 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRPL53 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MRPL53 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...